CTOs on the Move


 
Dentive is a dental service organization that provides business consulting and services to dentists.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

g.b.cooley hospital service district

g.b.cooley hospital service district is a Monroe, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Myomo

Myomo Inc is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Partnership HealthPlan of California

"The Partnership HealthPlan of California, ""The HealthPlan,"" began operations in May 1994, and is a public and private organization designed to provide a cost-effective health care delivery system to Medi-Cal recipients in California 's Solano, Napa, Yolo, and Sonoma Counties."

Occupational Health and Hygiene Corporation of America

Occupational Health and Hygiene Corporation of America is a Lebanon, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.